Title : Inhibition of CDK2 reduces EZH2 phosphorylation and reactivates ERĪ± expression in high-grade serous ovarian carcinoma.

Pub. Date : 2020

PMID : 32368395






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The cyclin-dependent kinase 2 (CDK2) inhibitor dinaciclib, a potential anti-cancer drug, has been tested in clinical trials and reported to suppress tumor initiating cells. dinaciclib cyclin dependent kinase 2 Homo sapiens
2 The cyclin-dependent kinase 2 (CDK2) inhibitor dinaciclib, a potential anti-cancer drug, has been tested in clinical trials and reported to suppress tumor initiating cells. dinaciclib cyclin dependent kinase 2 Homo sapiens